TrialJournal of radiation research2025

Postoperative hyperfractionated IMRT with weekly cisplatin for head and neck cancer: phase IIa trial.

Shinya Hiraoka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.